Beneficial impact of preconditioning during PTCA on creatine kinase release.

BACKGROUND Previous studies in humans have indicated that there is less ischemic dysfunction during PTCA when ischemic preconditioning is elicited. However, the clinical relevance of these observations remains unclear. The present study design tests the hypothesis that PTCA performed to elicit the preconditioning response would result in less myocardial necrosis as assessed by postprocedure creatine kinase (CK) levels. METHODS AND RESULTS Patients (n=150) undergoing PTCA for unstable ischemic syndromes were randomly assigned to receive a previously validated approach to PTCA-mediated preconditioning (PC) or an unrestricted approach to balloon angioplasty (UC). CK levels were determined at 8, 12, and, if necessary, 24 hours. Clinical success rates were equivalent for the 2 groups. However, the frequency of any CK elevation was significantly higher in the UC group (25%) than in the PC group (7. 1%) (P<0.005). Multivariable analysis confirmed a significant effect of preconditioning on CK release. CONCLUSIONS A standardized protocol to elicit preconditioning during PTCA results in a significant reduction in the rate of CK elevation in a high-risk population. These observations support the clinical relevance of ischemic preconditioning in humans.

[1]  Marshall A. Lichtman,et al.  Commentary on and reprint of EPIC (Evaluation of 7E3 for the Prevention of Ischemic Complications) Investigators, The, Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty, in New England Journal of Medicine (1994) 330:956–961 , 2000 .

[2]  E. Braunwald,et al.  Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. , 1998, Circulation.

[3]  R. Califf,et al.  Myonecrosis after revascularization procedures. , 1998, Journal of the American College of Cardiology.

[4]  V. Paul,et al.  Recruited collateral channels are not responsible for ischemic preconditioning during single vessel angioplasty , 1998 .

[5]  M. Hori,et al.  Different mechanisms of ischemic adaptation to repeated coronary occlusion in patients with and without recruitable collateral circulation. , 1997, Journal of the American College of Cardiology.

[6]  W. Laskey,et al.  Ischemic preconditioning in unstable coronary syndromes: evidence for time dependence. , 1997, Journal of the American College of Cardiology.

[7]  Y. Kira,et al.  Effect of time interval between two balloon inflations on ischemic preconditioning during coronary angioplasty. , 1997, Catheterization and cardiovascular diagnosis.

[8]  F. Crea,et al.  Phentolamine prevents adaptation to ischemia during coronary angioplasty: role of alpha-adrenergic receptors in ischemic preconditioning. , 1997, Circulation.

[9]  David P Miller,et al.  Long-term Protection From Myocardial Ischemic Events in a Randomized Trial of Brief Integrin β3 Blockade With Percutaneous Coronary Intervention , 1997 .

[10]  David P Miller,et al.  Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication. , 1997, JAMA.

[11]  R. Bolli,et al.  Preconditioning of human myocardium with adenosine during coronary angioplasty. , 1997, Circulation.

[12]  W. Laskey,et al.  Creatine kinase release after catheter-based coronary intervention. , 1997, Catheterization and cardiovascular diagnosis.

[13]  D. Yellon,et al.  Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. , 1997, Heart.

[14]  Ohman Em,et al.  Periprocedural cardiac marker elevation after percutaneous coronary artery revascularization. Importance and implications. , 1997 .

[15]  R. Bonow,et al.  Prognostic implication of creatine kinase elevation following elective coronary artery interventions. , 1997, JAMA.

[16]  E. M. Ohman,et al.  Periprocedural cardiac marker elevation after percutaneous coronary artery revascularization. Importance and implications. , 1997, JAMA.

[17]  E. Topol,et al.  The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures. , 1996, Circulation.

[18]  B. Strauer,et al.  Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance. , 1996, Journal of the American College of Cardiology.

[19]  E. Topol,et al.  Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. , 1996, Circulation.

[20]  F. Crea,et al.  Effects of A1 adenosine receptor blockade by bamiphylline on ischaemic preconditioning during coronary angioplasty. , 1996, European heart journal.

[21]  G. Pelle,et al.  Repeated coronary artery occlusions during routine balloon angioplasty do not induce myocardial preconditioning in humans. , 1996, Journal of the American College of Cardiology.

[22]  C. Vrints,et al.  Aminophylline inhibits adaptation to ischaemia during angioplasty. Role of adenosine in ischaemic preconditioning. , 1996, European heart journal.

[23]  M. Leon,et al.  Predictors of late mortality following ablative new-device angioplasty in native coronary arteries , 1996 .

[24]  M. Galvani,et al.  Prodromal angina limits infarct size. A role for ischemic preconditioning. , 1995, Circulation.

[25]  C. Cannon,et al.  Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? , 1995, Circulation.

[26]  R. Kloner,et al.  Does ischemic preconditioning occur in patients? , 1994, Journal of the American College of Cardiology.

[27]  M. Josephson,et al.  Ischemia-induced changes in human endocardial electrograms during percutaneous transluminal coronary angioplasty. , 1994, American heart journal.

[28]  Epic Investigators,et al.  Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. , 1994, The New England journal of medicine.

[29]  J. Douglas,et al.  Angiographic predictors of a rise in serum creatine kinase (distal embolization) after balloon angioplasty of saphenous vein coronary artery bypass grafts. , 1993, The American journal of cardiology.

[30]  D. Yellon,et al.  Preconditioning the human myocardium , 1993, The Lancet.

[31]  A. Cribier,et al.  Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: a prospective study. , 1992, Journal of the American College of Cardiology.

[32]  J. Downey,et al.  Protection Against Infarction Afforded by Preconditioning is Mediated by A1 Adenosine Receptors in Rabbit Heart , 1991, Circulation.

[33]  W. Laskey,et al.  Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. , 1990, Circulation.

[34]  F. Lucchese,et al.  Subaortic fibrous ridge and ventricular septal defect: role of septal malalignment. , 1987, Circulation.

[35]  R. Jennings,et al.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.